Shredded documents and trick cameras: FDA knocks Indian drugmaker Windlas for brazen errors
When the FDA comes down on drug manufacturers, it can be for a range of wrongdoings, including poor testing policies and unsanitary conditions. But shredding key documents and leading investigators to incorrect rooms during an inspection? That’s a bold move, and Indian drugmaker Windlas could pay the price. The FDA said Windlas Healthcare failed to adequately address… Read More »